# Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias

> **NCT05321940** · PHASE1 · WITHDRAWN · sponsor: **Juan C. Ramos, MD**

## Conditions studied

- Refractory Leukemia
- Relapsed Leukemia
- Acute Myelogenous Leukemia
- Acute Lymphoblastic Leukemia
- Adult T-Cell Leukemia/Lymphoma

## Interventions

- **BIOLOGICAL:** STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
- **BIOLOGICAL:** Dendritic Cell Vaccine

## Key facts

- **NCT ID:** NCT05321940
- **Lead sponsor:** Juan C. Ramos, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-11-30
- **Primary completion:** 2025-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator decision
- **Last updated:** 2023-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05321940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05321940, "Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05321940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*